Generate Biomedicines (ticker: GENB) will IPO before 5pm EST on March 31, 2026

High probability for Generate Biomedicines to IPO by March 31, 2026.

The prediction market shows a strong consensus with a 99% probability that Generate Biomedicines will complete its IPO before the deadline. This aligns closely with the Pulse AI probability of 94%, indicating a high level of confidence among participants. However, the edge of -5 suggests that the market is fairly priced, reflecting balanced expectations.

• 1 Current market sentiment is overwhelmingly positive towards the IPO.
• 2 The high probabilities indicate strong confidence in the company's plans.
• 3 Historical data on biotech IPOs may support these predictions.
• 4 Liquidity in the market appears stable, allowing for smooth trading.
• 5 Time pressure is moderate with 401 hours until the deadline.